{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-23-005823","form_type":"8-K","ticker":"FZMD","cik":"0000319016","company_name":"Fuse Medical, Inc.","filed_at":"2023-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.781062+00:00","generated_at":"2026-06-17T00:57:24.056521+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Fuse Medical reports FY 2022 net income of $3.1M, swing from prior-year loss; revenue down 9%","bullets":["Net revenue $18.6M (-9% YoY); gross profit margin improved to 62% from 58%.","Net income of $3.1M vs net loss of $1.59M in FY 2021, a swing of $4.69M.","Adjusted EBITDA loss narrowed to ~$1.0M from ~$2.0M (improvement of ~50%).","SG&A down 7% to $6.5M; commissions expense down 20% to $5.7M.","CEO Reeg: focus in 2023 on design, development, commercialization, and expanding direct sales force."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-23-005823","json":"https://secwatch.observer/filing/0001564590-23-005823.json","markdown":"https://secwatch.observer/filing/0001564590-23-005823.md","text":"https://secwatch.observer/filing/0001564590-23-005823.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/319016/000156459023005823/0001564590-23-005823-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/319016/000156459023005823/fzmd-8k_20230414.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T00:57:24.056521+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d1f5862fd21916a84bbde4ea87141bf9deef71a1","claim":"Fuse Medical, Inc. reported the year ended December 31, 2022 results: revenue $18.6 million, net income $3.1 million.","evidence_excerpt":"Net revenues for the year ended December 31, 2022 were $18.6 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/319016/000156459023005823/0001564590-23-005823-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2022"},{"label":"Revenue","value":"$18.6 million"},{"label":"Net income","value":"$3.1 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}